Pharmacovigilance services for the Pharmaceutical Industry.

Information about PVpharm

José Ortiz to participate as a speaker in the DIA QPPV forum 2022
Jose Ortiz will be presenting on the QPPV forum 2022 organized by DIA

José Ortiz to participate as a speaker in the DIA QPPV forum 2022

  • September 17, 2022

José Ortiz, PVpharm CEO will participate one more time as a speaker in the next QPPV forum organized by DIA. You can find more information in the link: https://www.diaglobal.org/en/conference-listing/meetings/2022/11/global-forum-for-qualified-persons-for-pharmacovigilance-qppv José will be presenting in the Session 2: Pharmacovigilance System Oversight on 09 Nov 2022 9:00 AM – 09 Nov 2022 10:30 AM https://www.diaglobal.org/en/conference-listing/meetings/2022/11/global-forum-for-qualified-persons-for-pharmacovigilance-qppv/agenda/09/session-2-pharmacovigilance-system-oversight?ref=Session2PharmacovigilanceSystemOversight About the QPPV forum: In a changing and expanding world, this is still the only forum designed for QPPVs by QPPVs, now celebrating its 16th year and still going strong. Back in a face-to-face format, it brings together QPPVs from all over the world to discuss how…

Continue Reading
PVpharm team summer offsite meeting in Almeria 2022
PVpharm team Arrecife de las Sirenas 2022

PVpharm team summer offsite meeting in Almeria 2022

  • September 8, 2022

The PVpharm team had a meeting in Almería on the 29th and 30th of August 2022. The team did several activities, including a hiking route from Arrecife de las Sirenas to Cala Rajá, in the Natural Park of Cabo de Gata. The route was coached by AGata Verde, an innovative project in the field of Environmental Education, aimed at providing tools for learning care and respect for the environment. We stopped for a swim in Cala Rajá. Afterwards there was a lunch and an swim and snorkeling in the beach of Las Salinas. On the next day the team had…

Continue Reading

CTIS for sponsors of clinical trials

  • July 28, 2022

Sponsors of clinical trials in the EU should be aware that the EMA’s Management Board, on 31 January 2022 established a harmonized approach to submission, assessment, and authorization of clinical trial applications.

Continue Reading